Effectiveness and tolerability of ferric carboymaltose in the correction of cancer- and chemotherapy-associated anaemia – a multicenter observational study. 1. Juni 2011 Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Rzychon, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011. chemotherapy-associated anaemia – a multicenter observational study. EMCC / ESMO (Poster 294, Abstract 3000). Ferric Carboxymaltose for the Correction of Cancer- and Chemotherapy-Assiciated Anemia in Clinical Practice. Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011. haematologica 96(s2), 0983. Weiterlesen Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer. Stemmler, H.J., Digioia, D., Freier, W., Tessen, H.W., Gitsch, G., Jonat, W., Brugger, W., Kettner, E., Abenhardt, W., Tesch, H., Hurtz, H.J., Rösel, S., Brudler,… Weiterlesen